{
    "clinical_study": {
        "@rank": "129269", 
        "arm_group": [
            {
                "arm_group_label": "123 I-HSA + 125 I-HSA", 
                "arm_group_type": "Active Comparator", 
                "description": "Healthy Volunteers, N=16"
            }, 
            {
                "arm_group_label": "123 I- HSA + 125 I-HSA", 
                "arm_group_type": "Experimental", 
                "description": "Patients, planned for elective Major Abdominal Surgery, N=16"
            }, 
            {
                "arm_group_label": "123-I-HSA+125 I-HSA", 
                "arm_group_type": "Experimental", 
                "description": "Patients, with a acute pancreatitis or cholecystitis, N=16"
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective, validation study of a extempore made tracer compared with a\n      commercial. Studies with tracer have no medical effects but are used for studying human\n      physiology, in this case pharmacokinetic variables of endogenous albumin distribution and\n      turnover at different levels of inflammation.\n\n        1. Primary Objective:\n\n           - Do the extempore made tracer 123-iodine labeled albumin an commercially manufactured\n           SERALB-125 give identical values of calculated blood plasma volume and capillary\n           leakage measured as transcapillary escape rate of albumin?\n\n        2. Secondary Objective:\n\n             -  How do three different measures of albumin turnover correlate in volunteers?\n\n             -  How do the pharmacokinetic parameters of endogenous albumin vary between the three\n                study groups?"
        }, 
        "brief_title": "A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Healthy", 
            "SIRS"
        ], 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  healthy volunteers (treatment arm I)\n\n          -  on contraceptive agent and/or contraceptive device\n\n          -  visual peripheral veins\n\n          -  signed informed consent\n\n          -  planned for elective larger interabdominal surgery (treatment arm II)\n\n          -  patients with a acute pancreatitis or cholecystitis (treatment arm III)\n\n        Exclusion Criteria:\n\n          -  pregnant women and/or lactating\n\n          -  allergy towards excipients in 123 I HSA or 125 I HSA\n\n          -  participates in another study involving radiation or stabile isotopes within a period\n             of   60 days to study start\n\n          -  it is the opinion of the principle investigator that the patient/subject should not\n             participate for his/hers own good"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686776", 
            "org_study_id": "3.00 # amended version 1.1"
        }, 
        "intervention": {
            "arm_group_label": [
                "123 I-HSA + 125 I-HSA", 
                "123 I- HSA + 125 I-HSA", 
                "123-I-HSA+125 I-HSA"
            ], 
            "description": "Compare and validate the method of measuring albumine turnover rate", 
            "intervention_name": "123 I-HSA + 125 I HSA", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Plasma albumine", 
            "Plasma volume", 
            "Transcapillary escape rate", 
            "Inflammation", 
            "Circulation"
        ], 
        "lastchanged_date": "January 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "SE-141 86"
                }, 
                "name": "Karolinska University Hospital, Huddinge"
            }, 
            "investigator": {
                "last_name": "\u00c5ke Norberg, M.D.,PhD.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Prospective Validation Study in Healthy Volunteers, Patients With Acute Inflammation and Patients Scheduled for Major Abdominal Surgery", 
        "other_outcome": {
            "description": "How well does the variables FSR, FCR1, FCR30 correlate? How does the pharmacokinetic parameters differ/varies between the three groups?", 
            "measure": "plasma albumin turnover rate", 
            "safety_issue": "No", 
            "time_frame": "42 days"
        }, 
        "overall_contact": {
            "email": "ake.norberg@karolinska.se", 
            "last_name": "\u00c5ke Norbebrg, M.D PhD", 
            "phone": "+46-8-58585159"
        }, 
        "overall_official": {
            "affiliation": "Karolinska University Hopsital", 
            "last_name": "Olav Rooyackers, PhDProfessor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Medical Products Agency.Amend approved#:151:2012/87317", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Is the measured value for 123-I-HSA and 125I-HSA identical/equal regarded TER and plasma volume (PV)?", 
            "measure": "Transcapillary Escape Rate (TER)of Albumin", 
            "safety_issue": "No", 
            "time_frame": "42 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686776"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska Institutet", 
            "investigator_full_name": "Ake Norberg", 
            "investigator_title": "M.D, PhD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Non compartmental analysis (NCA) and AUC (time-conc) will be determine the pharmacokinetics like clearance, distribution volume and absolute catabolic rate", 
            "measure": "Fractional catabolic rate (FCR)", 
            "safety_issue": "No", 
            "time_frame": "42 days"
        }, 
        "source": "Karolinska Institutet", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ake Norberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}